MCNOs/CdS双效光催化剂的制备及其性能研究

水热合成法制备了不同磁性纳米洋葱碳(MCNOs)负载量(0%、1%、3%、5%)的MCNOs/CdS光催化剂。并通过X射线衍射分析(XRD)、扫描电子显微镜(SEM)、傅里叶红外光谱(FT-IR)、X射线光电子能谱(XPS)、紫外可见光光谱(UV-Vis)、磁滞回线测定仪(VSM)对其进行表征,探究了MCNOs负载比例对催化剂在可见光下降解RhB性能及机理的影响。结果表明,MCNOs能有效提高CdS的光催化效果,复合3%MCNOs后降解率为96%,与纯CdS相比降解率提高了30%,磁性分析表明,其具有良好的顺磁性并能实现催化剂的有效回收。MCNOs/CdS在可见光下催化降解RhB的一级反应动力学直线有较好的拟合度,表明制备的催化剂有较好的催化活性。     

对流扩散方程的QC3无网格法

对流扩散方程作为偏微分运动方程的分支,在流体力学、气体动力学等领域有着重要应用.为解决对流扩散方程难以通过解析法得到解析解的难题,采用二阶一致3点积分(Quadratically Consistent 3-Point Integration,简称QC3)提高无网格法的计算效率,通过对积分点上形函数导数的修正,改善无网格法的精度和收敛性.本文将QC3无网格法拓展到对流扩散方程问题中,时域离散采用广义特征线Galerkin法,空间离散采用QC3法.数值结果表明,应用QC3无网格法得到的对流扩散问题数值解与解析解十分接近,验证了QC3无网格法解决对流扩散问题的可行性.     

基于模糊神经元PID算法的注塑机注射速度控制算法研究

基于一款市场较为畅销的注塑机, 设计出一种能精确控制注射速度的模糊神经元PID控制器. 首先, 设计出具有自学能力的神经元PID控制器, 利用模糊算法对其进行优化; 其次, 在原有注射速度线性数学模型的基础上, 构建注塑机注射速度的非线性模型; 最后, 利用MATLAB在所建数学模型的基础上对模糊神经元PID控制器进行仿真实验. 实验结果表明, 所设计控制器具有响应迅速、无超调量、控制精度高、控制稳定等优点.     

基于不确定控制理论的最优策略研究

本文在不确定理论的框架下,研究一类带背景状态变量的最优控制模型.在乐观值准则下,利用不确定动态规划的方法,证明了不确定最优性原则,得到最优性方程.作为应用,求解一个固定缴费(DC)型养老金的最优投资策略问题,在乐观值准则下,以工资变量为背景状态变量,建立养老金模型.通过求解不确定最优性方程得到最优投资策略和最优支付率.     

From differential equation solvers to accelerated first-order methods for convex optimization

Mathematical Programming - Convergence analysis of accelerated first-order methods for convex optimization problems are developed from the point of view of ordinary differential equation solvers. A...     

基于差分反射高光谱成像的薄层TMDC材料检测技术研究

二维过渡金属硫化物(TMDC)材料因为独特的激子效应和材料学性质，在太阳电池、光催化、传感器、柔性电子器件等领域得到广泛的应用。层数对其性质有显著的调控作用，自动检测识别所需层数的样品是其从实验室走进半导体制造工业的重要技术需求。本文结合反射高光谱成像技术与图像处理算法，发展了一种二维TMDC薄层样品的显微成像自动检测技术。基于自主搭建的反射高光谱成像系统，对制备的不同层数TMDC标准样品进行了光学对比度的系统研究，阐明了层数的差分反射光谱机理，提出了可靠的层数判定方法。基于传统边缘检测技术优化设计了一套图像处理算法，实现了TMDC样品的图像检测及层数鉴定。本文方法具有普遍性、实用性，结合自动对焦的扫描控制，能够实现大规模的自动化样品检测，这也为其他表面目标的显微识别和检测提供了新的灵感和参考。     

A microfluidics-dispensing-printing strategy for Janus photonic crystal microspheres towards smart patterned displays

From the implementation point of view, the printable magnetic Janus colloidal photonic crystals (CPCs) microspheres are highly desirable. Herein, we developed a dispensing-printing strategy for magnetic Janus CPCs display via a microfluidics-automatic printing system. Monodisperse core/shell colloidal particles and magnetic Fe₃O₄ nanoparticles precursor serve as inks. Based on the equilibrium of three-phase interfacial tensions, Janus structure is successfully formed, followed by UV irradiation and self-assembly of colloid particle to generate magnetic Janus CPCs microspheres. Notably, this method shows distinct superiority with highly uniform Janus CPCs structure, where the TMPTA/Fe₃O₄ hemisphere is in the bottom side while CPCs hemisphere is in the top side. Thus, by using Janus CPCs microspheres with two different structural colors as pixel points, a pattern with red flower and green leaf is achieved. Moreover, 1D linear Janus CPCs pattern encapsulated by hydrogel is also fabricated. Both the color and the shape can be changed under the traction of magnets, showing great potentials in flexible smart displays. We believe this work not only offers a new feasible pathway to construct magnetic Janus CPCs patterns by a dispensing-printable fashion, but also provides new opportunities for flexible and smart displays.     

Anti-fibrosis attributes: UHPLC-MS/MS-based pharmacokinetics profiling of a novel autotaxin inhibitor with excellent in vivo efficacy in rat

3,4-Difluorobenzyl(1-ethyl-5-(4-((4-hydroxypiperidin-1-yl)-methyl)thiazol-2-yl)-1H-indol-3-yl)carbamate (NAI59), a small molecule with outstanding therapeutic effectiveness to anti-pulmonary fibrosis, was developed as an autotaxin inhibitor candidate compound. To evaluate the pharmacokinetics and plasma protein binding of NAI59, a UPLC–MS/MS method was developed to quantify NAI59 in plasma and phosphate-buffered saline. The calibration curve linearity ranged from 9.95 to 1990.00 ng/mL in plasma. The accuracy was −6.8 to 5.9%, and the intra- and inter-day precision was within 15%. The matrix effect and recovery, as well as dilution integrity, were within the criteria. The chromatographic and mass spectrometric conditions were also feasible to determine phosphate-buffered saline samples, and it has been proved that this method exhibits good precision and accuracy in the range of 9.95–497.50 ng/mL in phosphate-buffered saline. This study is the first to determine the pharmacokinetics, absolute bioavailability, and plasma protein binding of NAI59 in rats using this established method. Therefore, the pharmacokinetic profiles of NAI59 showed a dose-dependent relationship after oral administration, and the absolute bioavailability in rats was 6.3%. In addition, the results of protein binding showed that the combining capacity of NAI59 with plasma protein attained 90% and increased with the increase in drug concentration.     

In vitro and in vivo evaluation of a novel anti-EGFR antibody labeled with 89Zr and 177Lu

Journal of Radioanalytical and Nuclear Chemistry - There is an urgent need to develop more specific targeted therapies for lung cancer treatment due to the its low survival rate. EGFR is a...